Targeted therapy for advanced salivary gland carcinoma based on molecular profiling: Results from MyPathway, a phase IIa multiple basket study

Authors

R Kurzrock, University of California - San Diego
D W Bowles, University of Colorado, Denver
H Kang, Johns Hopkins University
F Meric-Bernstam, The University of Texas MD Anderson Cancer Center
J Hainsworth, Sarah Cannon Research Institute
D R Spigel, Sarah Cannon Research Institute
R Bose, Washington University School of Medicine in St. Louis
H Burris, Sarah Cannon Research Institute
C J Sweeney, Harvard University
M S Beattie, Genentech, Inc.
S Blotner, Genentech, Inc.
K Schulze, Genentech, Inc.
V Cuchelkar, Genentech, Inc.
C Swanton, Francis Crick Institute

Journal

Annals of oncology

Publication Date

3-1-2020

Volume

31

Issue

3

First Page

412

Last Page

421

Document Type

Open Access Publication

DOI

10.1016/j.annonc.2019.11.018

Rights and Permissions

Kurzrock R, Bowles DW, Kang H, Meric-Bernstam F, Hainsworth J, Spigel DR, Bose R, Burris H, Sweeney CJ, Beattie MS, Blotner S, Schulze K, Cuchelkar V, Swanton C. Targeted therapy for advanced salivary gland carcinoma based on molecular profiling: results from MyPathway, a phase IIa multiple basket study. Ann Oncol. 2020 Mar;31(3):412-421. doi: 10.1016/j.annonc.2019.11.018.

Recommended Citation

Kurzrock, R; Bowles, D W; Kang, H; Meric-Bernstam, F; Hainsworth, J; Spigel, D R; Bose, R; Burris, H; Sweeney, C J; Beattie, M S; Blotner, S; Schulze, K; Cuchelkar, V; and Swanton, C, "Targeted therapy for advanced salivary gland carcinoma based on molecular profiling: Results from MyPathway, a phase IIa multiple basket study." Annals of oncology. 31, 3. 412 - 421. (2020).
https://digitalcommons.wustl.edu/oa_4/287